相关实验视频
Updated: Jul 4, 2025

A Swine Model of Neonatal Asphyxia
Published on: October 11, 2011
在新生儿败血性休克中,诺拉丁上腺素的血液动力学效应:一项前性队列研究
Aditya Kallimath1, Reema Garegrat1, Suprabha Patnaik1
1Department of Neonatology, Bharati University Medical College, Pune 411043, India.
诺拉德林在治疗新生儿感染性休克,改善婴儿血压和心脏功能方面表现有前途. 需要进一步的研究来确认其作为一线治疗的有效性.
科学领域:
- 新生儿科学 新生儿科学
- 儿科重症监护 儿科重症监护
- 药理学 药理学是指药理学的学科.
背景情况:
- 新生儿败血性休克在低收入国家有很高的发病率 (26.8%) 和死亡率 (35.4%).
- 有限的证据存在于新生儿中诺亚上腺素的血液动力学影响.
- 这项研究解决了对新生儿败血性休克中诺亚上腺素疗效的数据需求.
研究的目的:
- 为了评估诺亚上腺素对被诊断患有败血性休克的新生儿的影响.
- 评估与诺亚上腺素使用相关的血液动力学反应和死亡率.
主要方法:
- 一个单一中心前性队列研究是在III级新生儿重症监护病房进行的.
- 包括接受诺亚上腺素作为第一线治疗的感染性休克新生儿.
- 临床和血液动力学参数在输入诺亚上腺素之前和一个小时后被测量.
主要成果:
- 76% (76.2%) 的新生儿在服用诺亚上腺素后一小时内显示出休克的消失.
- 平均血压从30.6mmHg增加到37.8mmHg (p < 0.001). 平均血压从30.6mmHg增加到37.8mmHg (p < 0.001). 平均血压从30.6mmHg增加到37.8mmHg (p < 0.001). 平均血压从30.6mmHg增加到37.8mmHg (p < 0.001).
- 分数缩短显著改善,死亡率为28.6%.
结论:
- 诺拉德林在改善新生儿败血性休克的血液动力学参数方面显示出潜在的潜力.
- 这种药物在增加平均血压和分数缩短方面似乎有效.
- 需要进行更大规模的研究,以验证诺拉丁上腺素作为新生儿败血性休克的第一线治疗.
更多相关视频
09:09Description of a Swine Infant Model of Volume-Controlled Hemorrhagic Shock
Published on: November 3, 2023
10:55A Piglet Perinatal Asphyxia Model to Study Cardiac Injury and Hemodynamics after Cardiac Arrest, Resuscitation, and the Return of Spontaneous Circulation
Published on: January 13, 2023
相关概念视频
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Adrenergic Neurons: Neurotransmission
Synthesis: Catecholamine synthesis requires tyrosine, which...
Adrenergic Agonists: Direct-Acting Agents
These agents can be classified...